Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Maintenance in Extensive-Stage SCLC
NCT00616109Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Sep 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in small cell lung cancer (SCLC), sponsored by University of Michigan Rogel Cancer Center. Started Sep 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00616109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616109.